Home/Filings/4/0001209191-18-005731
4//SEC Filing

SCHAFER GREGORY W 4

Accession 0001209191-18-005731

CIK 0001435049other

Filed

Jan 25, 7:00 PM ET

Accepted

Jan 26, 7:15 PM ET

Size

10.6 KB

Accession

0001209191-18-005731

Insider Transaction Report

Form 4
Period: 2018-01-25
SCHAFER GREGORY W
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2018-01-25$0.82/sh+60,000$49,200250,745 total
  • Exercise of In-Money

    Common Stock Warrant (right to buy)

    2018-01-253,3170 total
    Exercise: $0.01From: 2013-09-30Exp: 2023-09-30Common Stock (3,317 underlying)
  • Exercise of In-Money

    Common Stock

    2018-01-25$0.01/sh+3,317$33254,062 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-01-2560,00087,322 total
    Exercise: $0.82Exp: 2023-11-26Common Stock (60,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the Option became fully vested and exercisable as of July 1, 2017.

Issuer

ADURO BIOTECH, INC.

CIK 0001435049

Entity typeother

Related Parties

1
  • filerCIK 0001193195

Filing Metadata

Form type
4
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 7:15 PM ET
Size
10.6 KB